Supplements and supportive compounds Clinical trial data shows that B vitamins, particularly B12, may help address some of the nutritional absorption changes that GLP-1 agonists can cause
Nielsen R, Jorsal A, Iversen P, Tolbod LP, Bouchelouche K, Srensen J, Harms HJ, Flyvbjerg A, Tarnow L, Kistorp C, et al
PT-141 for men: A new drug to treat ED and low libido

Host-at-a-Glance Name: Gil Blander What he does: Founder and CSO Company: InsideTracker Noteworthy: Expert in longevity, nutrition, and personalized health optimization Host-at-a-Glance Name: Ashley Reaver What she does: Lead Nutrition Scientist Company: InsideTracker Noteworthy: Specializes in metabolism, nutrition, and biomarker-based health strategies Episode highlights: [00:00:00] Introduction [00:02:02] Understanding GLP-1 Hormones [00:04:26] GLP-1 Receptor Agonists: Mechanism and Benefits [00:06:50] Impact of GLP-1 on Weight and Health [00:21:16] Side Effects and Considerations of GLP-1 Agonists [00:26:31] The Future of GLP-1 Agonists [00:34:54] Exploring Wearables for Health [00:36:08] Choosing the Right Wearable [00:40:29] Wearables for Detecting Illness and Falls [00:47:12] Conclusion and Final Thoughts Key Insights GLP-1 Agonists: A Breakthrough for Weight and Metabolic Health GLP-1 agonists, originally developed for type 2 diabetes, have become a game-changer for weight loss, appetite control, and longevity

alpha-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes